These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 17132404)

  • 41. [Pediatric nonalcoholic fatty liver disease/nonalcoholic steatohepatitis].
    Takahashi Y; Fukusato T; Inui A; Fujisawa T
    Nihon Rinsho; 2012 Oct; 70(10):1827-34. PubMed ID: 23198569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Nonalcoholic steatohepatitis--current treatment options].
    Gutkowski K; Gutkowska D; Partyka M
    Przegl Lek; 2006; 63(2):91-4. PubMed ID: 16967716
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Nonalcoholic steatohepatitis in children].
    Cubelić S; Misak Z; Gasparov S; Kolacek S
    Lijec Vjesn; 2004; 126(7-8):197-200. PubMed ID: 15754789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Nonalcoholic steatohepatitis: epidemiology, diagnosis and treatment].
    Tilg H
    Dtsch Med Wochenschr; 2001 Apr; 126(16):467-71. PubMed ID: 11360453
    [No Abstract]   [Full Text] [Related]  

  • 46. Nonalcoholic fatty liver disease: a practical approach to evaluation and management.
    Rafiq N; Younossi ZM
    Clin Liver Dis; 2009 May; 13(2):249-66. PubMed ID: 19442917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of bariatric surgery on nonalcoholic steatohepatitis.
    Rabl C; Campos GM
    Semin Liver Dis; 2012 Feb; 32(1):80-91. PubMed ID: 22418890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonalcoholic fatty liver disease.
    Adams LA; Lindor KD
    Ann Epidemiol; 2007 Nov; 17(11):863-9. PubMed ID: 17728149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD)].
    Oe K; Ochi T; Hayase Y; Saibara T
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():406-9. PubMed ID: 21766632
    [No Abstract]   [Full Text] [Related]  

  • 51. Nonalcoholic fatty liver disease: predisposing factors and the role of nutrition.
    Cave M; Deaciuc I; Mendez C; Song Z; Joshi-Barve S; Barve S; McClain C
    J Nutr Biochem; 2007 Mar; 18(3):184-95. PubMed ID: 17296492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nutrition in pathophysiology and treatment of nonalcoholic fatty liver disease.
    Moschen AR; Tilg H
    Curr Opin Clin Nutr Metab Care; 2008 Sep; 11(5):620-5. PubMed ID: 18685459
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment.
    Carter-Kent C; Zein NN; Feldstein AE
    Am J Gastroenterol; 2008 Apr; 103(4):1036-42. PubMed ID: 18177455
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C infection and nonalcoholic fatty liver disease.
    Cheung O; Sanyal AJ
    Clin Liver Dis; 2008 Aug; 12(3):573-85, viii-ix. PubMed ID: 18625429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Obesity-associated nonalcoholic fatty liver disease.
    Yilmaz Y; Younossi ZM
    Clin Liver Dis; 2014 Feb; 18(1):19-31. PubMed ID: 24274862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Non-alcoholic steatohepatitis].
    García Monzón C
    Gastroenterol Hepatol; 2001 Oct; 24(8):395-402. PubMed ID: 11674960
    [No Abstract]   [Full Text] [Related]  

  • 58. Nonalcoholic steatohepatitis.
    Neuschwander-Tetri BA; Bacon BR
    Med Clin North Am; 1996 Sep; 80(5):1147-66. PubMed ID: 8804378
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutic strategies in nonalcoholic fatty liver disorders.
    Poordad FF
    Expert Opin Emerg Drugs; 2005 May; 10(2):237-9. PubMed ID: 15934865
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD).
    Ali R; Cusi K
    Ann Med; 2009; 41(4):265-78. PubMed ID: 19353360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.